Omicron BQ variants resistant to antibody treatments are quickly becoming dominant in U.S.

Omicron subvariants BQ.1 and BQ.1.1 now make up 44% of new Covid cases, compared with 32% last week, according to CDC data.

from US Top News and Analysis https://ift.tt/1gjKVXS
https://ift.tt/JnYSap3